Ogi K - Search Results

1

Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer.

Satoh A, Toyota M, Itoh F, Sasaki Y, Suzuki H, Ogi K, Kikuchi T, Mita H, Yamashita T, Kojima T, Kusano M, Fujita M, Hosokawa M, Endo T, Tokino T, Imai K. Satoh A, et al. Among authors: ogi k. Cancer Res. 2003 Dec 15;63(24):8606-13. Cancer Res. 2003. PMID: 14695171

2

pRb2/p130 protein expression is correlated with clinicopathologic findings in patients with oral squamous cell carcinoma.

Tanaka N, Ogi K, Odajima T, Dehari H, Yamada S, Sonoda T, Kohama G. Tanaka N, et al. Among authors: ogi k. Cancer. 2001 Oct 15;92(8):2117-25. doi: 10.1002/1097-0142(20011015)92:8<2117::aid-cncr1553>3.0.co;2-o. Cancer. 2001. PMID: 11596028

3

Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma.

Ogi K, Toyota M, Ohe-Toyota M, Tanaka N, Noguchi M, Sonoda T, Kohama G, Tokino T. Ogi K, et al. Clin Cancer Res. 2002 Oct;8(10):3164-71. Clin Cancer Res. 2002. PMID: 12374684

4

Epigenetic inactivation of CHFR in human tumors.

Toyota M, Sasaki Y, Satoh A, Ogi K, Kikuchi T, Suzuki H, Mita H, Tanaka N, Itoh F, Issa JP, Jair KW, Schuebel KE, Imai K, Tokino T. Toyota M, et al. Among authors: ogi k. Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7818-23. doi: 10.1073/pnas.1337066100. Epub 2003 Jun 16. Proc Natl Acad Sci U S A. 2003. PMID: 12810945 Free PMC article.

5

Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.

Obata T, Toyota M, Satoh A, Sasaki Y, Ogi K, Akino K, Suzuki H, Murai M, Kikuchi T, Mita H, Itoh F, Issa JP, Tokino T, Imai K. Obata T, et al. Among authors: ogi k. Clin Cancer Res. 2003 Dec 15;9(17):6410-8. Clin Cancer Res. 2003. PMID: 14695142

6

Epigenetic inactivation of TMS1/ASC in ovarian cancer.

Terasawa K, Sagae S, Toyota M, Tsukada K, Ogi K, Satoh A, Mita H, Imai K, Tokino T, Kudo R. Terasawa K, et al. Among authors: ogi k. Clin Cancer Res. 2004 Mar 15;10(6):2000-6. doi: 10.1158/1078-0432.ccr-0932-03. Clin Cancer Res. 2004. PMID: 15041718

7

Enhanced Bax in oral SCC in relation to antitumor effects of chemotherapy.

Takemura K, Noguchi M, Ogi K, Tokino T, Kubota H, Miyazaki A, Kohama G, Hiratsuka H. Takemura K, et al. Among authors: ogi k. J Oral Pathol Med. 2005 Feb;34(2):93-9. doi: 10.1111/j.1600-0714.2004.00257.x. J Oral Pathol Med. 2005. PMID: 15641988

8

Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors.

Ogi K, Toyota M, Mita H, Satoh A, Kashima L, Sasaki Y, Suzuki H, Akino K, Nishikawa N, Noguchi M, Shinomura Y, Imai K, Hiratsuka H, Tokino T. Ogi K, et al. Cancer Biol Ther. 2005 Jul;4(7):773-80. doi: 10.4161/cbt.4.7.1896. Epub 2005 Jul 6. Cancer Biol Ther. 2005. PMID: 16123600 Free article.

9

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

Terasawa K, Toyota M, Sagae S, Ogi K, Suzuki H, Sonoda T, Akino K, Maruyama R, Nishikawa N, Imai K, Shinomura Y, Saito T, Tokino T. Terasawa K, et al. Among authors: ogi k. Br J Cancer. 2006 Mar 27;94(6):914-21. doi: 10.1038/sj.bjc.6602984. Br J Cancer. 2006. PMID: 16479257 Free PMC article.

10

Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma.

Imai T, Toyota M, Suzuki H, Akino K, Ogi K, Sogabe Y, Kashima L, Maruyama R, Nojima M, Mita H, Sasaki Y, Itoh F, Imai K, Shinomura Y, Hiratsuka H, Tokino T. Imai T, et al. Among authors: ogi k. Cancer Sci. 2008 May;99(5):958-66. doi: 10.1111/j.1349-7006.2008.00769.x. Epub 2008 Feb 24. Cancer Sci. 2008. PMID: 18294275 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters